Table 4.
Differences in apoptosis markers of patients with CLL (N = 22) during the DI2 with High OC/OL-EVOO. a
| Apoptotic Markers | Baseline a Median (min–max) |
3 months b Median (min–max) |
6 months c Median (min–max) |
p-value (adj) |
|---|---|---|---|---|
| ccK18 (U/L) |
130.78 (40.39–400.45) |
128.56 (46.94–585.58) |
220.00 (76.50–385.50) |
a–c 0.013
b–c 0.013 |
| Apo1-Fas (U/L) |
91.84 (53.33–202.31) |
95.36 (66.01–611.81) |
140.87 (70.00–855.41) |
a–c 0.000
b–c 0.025 |
| Survivin/API4 (pg/ml) | 159.70 (62.65–429.50) |
107.64 (62.13–256.58) |
86.60 (35.00–125.00) |
a–c 0.000
b–c 0.002 |
a
Analysis was carried using Friedman test and Dunn–Bonferroni post hoc tests.
Bold emphasize statistical significant values.